We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Astra Tech, part of the AstraZeneca group that develops and manufactures dental
implants and medical devices for surgery and urology, has appointed Scott Root
as president and CEO.
International medical technology company Ventracor has initiated legal action
in the U.S. District Court for the Southern District of Florida against Heartware.
Light BioScience has announced that the FDA cleared GentleWaves Light Emitting
Diode (LED) Photomodulation System for the noninvasive treatment of periorbital
-- eye area -- wrinkles and rhytids.
VisionCare Ophthalmic Technologies, a developer of proprietary visual prosthetic
devices for the treatment of age-related macular degeneration (AMD) and other
central vision disorders, has closed a Series D financing totaling $20 million.
Ophthalmic Imaging Systems (OISI), a provider of ophthalmic digital imaging
systems, has received a commitment from Boston-based Dutchess Private Equities
Fund to purchase up to $9 million of OISI's common stock during a 30-month period.
Dual-chamber pacemakers may be more expensive than single-chamber models, but
they're worth it because they reduce the risk of hospitalization and disability,
a new study finds.
Gen-Probe licensed technology from AdnaGen, a private company based in Germany,
that may help increase the accuracy of molecular diagnostic tests to detect
prostate and other cancers, help determine the aggressiveness of these malignancies
and monitor responses to therapy.
Alliance Imaging, a national provider of diagnostic imaging services, has successfully
completed the sale of $150 million in aggregate principal amount of its 7 1/4
percent Senior Subordinated Notes due 2012 in a private placement transaction.
VitalWorks, a leader in radiology and diagnostic image and information technology
solutions, has completed the sale of its medical division to Cerner for $100
million in cash pursuant to the definitive agreement signed Nov. 15, 2004.